India’s Minister of Health and Family Welfare, Chemicals and Fertilisers, Dr Mansukh Mandaviya has invited global investors to invest and strengthen the Make-in-India programme.
India is leading in the development and production of Covid vaccine and helping the world in the fight against Corona Dr Mandaviya said at the India Pavilion at Expo 2020 Dubai.
The Minister said: “Investors have tremendous opportunities in India because it is a strong democratic country, ease of doing business is a big facilitator, and under the leadership of Prime Minister Narendra Modi, the pace of development has increased. The middle class is expanding, and their consumption power is rising. The Prime Minister has invited the global investors to come to the country and invest to strengthen Make-in-India.”
On India’s fightback against Corona, the Health Minister said: “India is a world leader in vaccine manufacturing sector. Two Indian companies have not only done the R&D but manufacturing of the vaccines also in the country. Our vaccine manufacturing capacity is 310 million doses per month and 86% of the population have got first dose of the vaccine while 55% of the population above 18 years of age have got the second dose. This is India’s strength.”
“We are providing ‘India-made, India-researched’ vaccines world over and helping everybody in getting protected against Covid,” he added.
On the India Pavilion, Dr Mandaviya said: “The Pavilion showcases India’s rich culture and its 75 years of journey and provides detailed information on its industries and development. With its theme of a New and Self-reliant India, the Pavilion truly showcases the principle of Vasudhaiva Kutumbakam (the world is one family) and rich cultural heritage of India.”
Dr Mandaviya also met Sultan Ahmed Bin Sulayem, Group Chairman and CEO, DP World and visited the pavilions of the UAE, the US and Saudi Arabia at Expo 2020.

 

Copyright 2021 Al Hilal Publishing and Marketing Group Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.